Collaboration Details

Print  Close


Title of Collaborative Activity:

NCI Cervical Cancer "Last Mile" Initiative (LMI)

Description of Collaborative Activity:

The NCI Cervical Cancer ‘Last Mile’ Initiative (LMI) is a public private partnership between several stakeholders (including federal agencies, industry partners, and professional societies/clinical practice guidelines organizations) to validate self-sampling-based HPV testing approaches as comparable (non-inferior) alternatives to provider-collected cervical specimen for HPV testing in cervical cancer screening, and accelerate progress towards regulatory approvals.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2021

NIH Participating Institutes/Centers/Office of the Director:

HHS Agency Collaborators on this Activity:

FDA, CDC